CRELD2 and metabolic dysfunction-associated steatohepatitis: They found sex dimorphism in the expression levels of CRELD2 in the human liver, where both the mRNA and protein levels of CRELD2 were significantly upregulated in male patients with non-alcoholic steatohepatitis (NASH); however, expression in female patients remained unaffected (94).